Cell Line News and Research

RSS
SARS-CoV-2 spike protein disrupts lipid metabolism resulting in liver, heart & kidney damage

SARS-CoV-2 spike protein disrupts lipid metabolism resulting in liver, heart & kidney damage

21 Apr 2022
Intranasal nanoparticle STING agonist with immunoantiviral activity against SARS-CoV-2 variants

Intranasal nanoparticle STING agonist with immunoantiviral activity against SARS-CoV-2 variants

21 Apr 2022
Study explores SARS-CoV-2 Omicron variant and infected colon epithelial cells

Study explores SARS-CoV-2 Omicron variant and infected colon epithelial cells

20 Apr 2022
High performance microplates for enhanced cell growth and survival

High performance microplates for enhanced cell growth and survival

From Porvair Sciences Limited 20 Apr 2022
Study identifies Etravirine and Dolutegravir as effective entry inhibitors of wild-type and predominant variants of SARS-CoV-2

Study identifies Etravirine and Dolutegravir as effective entry inhibitors of wild-type and predominant variants of SARS-CoV-2

18 Apr 2022
RNA interference triggers that target SARS-CoV-2 genome

RNA interference triggers that target SARS-CoV-2 genome

18 Apr 2022
Researchers find novel inhibitors that may suppress oncogenesis of metastatic prostate cancer

Researchers find novel inhibitors that may suppress oncogenesis of metastatic prostate cancer

13 Apr 2022
Scientists find critical role for Hippo signaling pathway in COVID-19 pathogenesis

Scientists find critical role for Hippo signaling pathway in COVID-19 pathogenesis

11 Apr 2022
Evidence of an increased risk of neurodegeneration after SARS-CoV-2 infection

Evidence of an increased risk of neurodegeneration after SARS-CoV-2 infection

11 Apr 2022
Study characterizes SARS-CoV-2 spike-specific cluster of differentiation 4+ T-cell response

Study characterizes SARS-CoV-2 spike-specific cluster of differentiation 4+ T-cell response

8 Apr 2022
Evidence SARS-CoV-2 undergoes ADAR-mediated A-to-I RNA editing in human cells

Evidence SARS-CoV-2 undergoes ADAR-mediated A-to-I RNA editing in human cells

4 Apr 2022
Natural compound found in cardamom shows promise for treating triple-negative breast cancer

Natural compound found in cardamom shows promise for treating triple-negative breast cancer

3 Apr 2022
Research demonstrates potential of local siRNA delivery as COVID antiviral therapy in the lung

Research demonstrates potential of local siRNA delivery as COVID antiviral therapy in the lung

3 Apr 2022
Study explores molecular mechanisms underlying SARS-CoV-2 infection of macrophages and the induction of pro-inflammatory cytokines

Study explores molecular mechanisms underlying SARS-CoV-2 infection of macrophages and the induction of pro-inflammatory cytokines

1 Apr 2022
Chemical in leafy greens could prevent infections by coronaviruses including SARS-CoV-2

Chemical in leafy greens could prevent infections by coronaviruses including SARS-CoV-2

30 Mar 2022
A summary of SARS-CoV-2 RNA-protein interactome studies

A summary of SARS-CoV-2 RNA-protein interactome studies

30 Mar 2022
Study analyzed several naturally-occurring amino acid variations found in the extended loop harboring the SARS-CoV-2 S1/S2 cleavage site

Study analyzed several naturally-occurring amino acid variations found in the extended loop harboring the SARS-CoV-2 S1/S2 cleavage site

30 Mar 2022
Antiviral functions of interferon regulatory factors during human coronavirus infection

Antiviral functions of interferon regulatory factors during human coronavirus infection

30 Mar 2022
Study shows that the SARS-CoV-2 envelope protein potently restricts HIV-1 infection

Study shows that the SARS-CoV-2 envelope protein potently restricts HIV-1 infection

30 Mar 2022
ProteoGenix launches new XtenCHOTM Transient CHO Expression System to improve biologics development

ProteoGenix launches new XtenCHOTM Transient CHO Expression System to improve biologics development

From ProteoGenix 30 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback